Magazine
Email Newsletter
RSS Feed
LinkedIn
Twitter
IN THE NEWS
Hinkaty Joins Physicians Formula from Del Labs
2009-10-20 | 08:33
Replaces Berry, who will become interim CFO.
Physicians Formula Holdings, Inc. appointed Charles Hinkaty to join the company's Board of Directors effective immediately. Mr. Hinkaty will be replacing Jeff Berry, who resigned as a director on May 29, 2009 to become interim chief financial officer of Physicians Formula.
The Board of Directors determined that Mr. Hinkaty qualifies as an independent director under the Nasdaq listing rules. In addition to his general appointment to the Board of Directors, Mr. Hinkaty will also join the Company's Audit, Compensation, and Nominating and Corporate Governance Committees of the Board of Directors.
Mr. Hinkaty was the president and chief executive officer of Del Laboratories, Inc. from August 2005 through his retirement in January 2008. Prior to that, Mr. Hinkaty was the chief operating officer of Del Laboratories, Inc. from January 2005 to August 2005, and vice president of Del Laboratories, Inc. and president of its subsidiary Del Pharmaceuticals, Inc. from 1985 to January 2005. Mr. Hinkaty served as a director of Del Laboratories, Inc. until December 2007 and has also been a member of the Board of Directors of FGX International since September 2008. He also led the Consumer Healthcare Products Association from 1999 to 2001.
"Charlie's long and impressive background in the cosmetics industry will further augment the expertise of our existing Board members," said Ingrid Jackel, chief executive officer. "Charlie's advice and counsel will be particularly relevant as we streamline our business model, expand our channel presence, pursue international opportunities and leverage our leadership in complementary face make-up."
"I am very pleased to be joining the Board of Directors of Physicians Formula," stated Mr. Hinkaty. "The company's passion and success in developing innovative solutions for everyday skin and beauty problems is abundantly clear in the creativity and dedication I see permeating throughout the organization."
The Board of Directors determined that Mr. Hinkaty qualifies as an independent director under the Nasdaq listing rules. In addition to his general appointment to the Board of Directors, Mr. Hinkaty will also join the Company's Audit, Compensation, and Nominating and Corporate Governance Committees of the Board of Directors.
Mr. Hinkaty was the president and chief executive officer of Del Laboratories, Inc. from August 2005 through his retirement in January 2008. Prior to that, Mr. Hinkaty was the chief operating officer of Del Laboratories, Inc. from January 2005 to August 2005, and vice president of Del Laboratories, Inc. and president of its subsidiary Del Pharmaceuticals, Inc. from 1985 to January 2005. Mr. Hinkaty served as a director of Del Laboratories, Inc. until December 2007 and has also been a member of the Board of Directors of FGX International since September 2008. He also led the Consumer Healthcare Products Association from 1999 to 2001.
"Charlie's long and impressive background in the cosmetics industry will further augment the expertise of our existing Board members," said Ingrid Jackel, chief executive officer. "Charlie's advice and counsel will be particularly relevant as we streamline our business model, expand our channel presence, pursue international opportunities and leverage our leadership in complementary face make-up."
"I am very pleased to be joining the Board of Directors of Physicians Formula," stated Mr. Hinkaty. "The company's passion and success in developing innovative solutions for everyday skin and beauty problems is abundantly clear in the creativity and dedication I see permeating throughout the organization."
